as identified by abnormal p53 suppressor gene immunohistochemistry, could be used as a complementary test to dysplasia to better identify patients at high risk for colorectal cancer. In a cohort ...

They applied the EMPaCT-pre-trained VirtualMultiplexer to a pancreatic ductal adenocarcinoma cohort (PDAC) TMA and generated virtual IHC images for CD44, CD146, and p53, as well as colorectal and ...